Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
A
Aspen Pharmacare Holdings Ltd
F:LDZA
Aspen Pharmacare Holdings Ltd
F:LDZA
Price:
9.4
EUR
3.3%
Market Closed
Market Cap:
€4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
LDZA Price Forecast
Based on 5 analysts
Based on 5 analysts
-46% Downside
from
€9.4
today
Aspen Pharmacare Holdings Ltd (LDZA)’s 12-month stock price forecast through November 2027 has a consensus target of €5.11, implying 46% downside. The forecast is based on price targets from 5 Wall Street analysts.
Aspen Pharmacare Holdings Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LDZA's stock price target?
Price Target
5.11
EUR
5.11
EUR
According to Wall Street analysts, the average 1-year price target for LDZA is 5.11 EUR with a low forecast of 4.66 EUR and a high forecast of 5.42 EUR.
What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
6%
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
33%
33%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
36%
36%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 36%.